Eugenio Marcuello
About
Eugenio Marcuello is a scholar working on Oncology, Pathology and Forensic Medicine and Hepatology.
According to data from OpenAlex, Eugenio Marcuello has authored 33 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Oncology, 11 papers in Pathology and Forensic Medicine and 7 papers in Hepatology. Recurrent topics in Eugenio Marcuello's work include Colorectal Cancer Treatments and Studies (25 papers), Cancer Treatment and Pharmacology (12 papers) and Genetic factors in colorectal cancer (9 papers). Eugenio Marcuello is often cited by papers focused on Colorectal Cancer Treatments and Studies (25 papers), Cancer Treatment and Pharmacology (12 papers) and Genetic factors in colorectal cancer (9 papers). Eugenio Marcuello collaborates with scholars based in Spain, Canada and United Kingdom. Eugenio Marcuello's co-authors include David Cunningham, István Láng, Vito Lorusso, Daniel Waterkamp, Mark Saunders, Janja Ocvirk, Derek J. Jonker, Dong Bok Shin, Stuart Osborne and Montserrat Baiget and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Cancer.
In The Last Decade
Eugenio Marcuello
33 papers receiving 1.6k citations
Hit Papers
Peers
Eugenio Marcuello
Janja Ocvirk Slovenia
H. Kröning Germany
Stephen A. Cullinan United States
Tadamichi Denda Japan
Rosella Spadi Italy
Isabel Chirivella Spain
George P. Kim United States
Marie‐Pierre Galais France
Cristina Grávalos Spain
Yihebali Chi China
Citations per year, relative to Eugenio Marcuello Eugenio Marcuello (= 1×)
peers
Janja Ocvirk
Countries citing papers authored by Eugenio Marcuello
Since
Specialization
Citations
This map shows the geographic impact of Eugenio Marcuello's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eugenio Marcuello with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eugenio Marcuello more than expected).
Fields of papers citing papers by Eugenio Marcuello
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Eugenio Marcuello. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eugenio Marcuello. The network helps show where Eugenio Marcuello may publish in the future.
Co-authorship network of co-authors of Eugenio Marcuello
This figure shows the co-authorship network connecting the top 25 collaborators of Eugenio Marcuello. A scholar is included among the top collaborators of Eugenio Marcuello based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eugenio Marcuello. Eugenio Marcuello is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Saunders, Mark, István Láng, Eugenio Marcuello, et al.. (2013). Results According to Age in Avex, a Randomized Phase 3 Trial of Bevacizumab with Capecitabine for Elderly Patients with Mcrc. Annals of Oncology. 24. iv23–iv23.
2.
Cunningham, David, István Láng, Eugenio Marcuello, et al.. (2013). Bevacizumab plus capecitabine versus capecitabine alone in elderly patients with previously untreated metastatic colorectal cancer (AVEX): an open-label, randomised phase 3 trial. The Lancet Oncology. 14(11). 1077–1085.
3.
Saunders, Mark, István Láng, Eugenio Marcuello, et al.. (2013). Efficacy and safety according to age subgroups in AVEX, a randomized phase III trial of bevacizumab in combination with capecitabine for the first-line treatment of elderly patients with metastatic colorectal cancer.. Journal of Clinical Oncology. 31(15_suppl). 3521–3521.
4.
Díaz‐Rubio, Eduardo, Auxiliadora Gómez‐España, Bartomeu Massutí, et al.. (2012). Role of Kras Status in Patients with Metastatic Colorectal Cancer Receiving First-Line Chemotherapy plus Bevacizumab: A TTD Group Cooperative Study. PLoS ONE. 7(10). e47345–e47345.
5.
Benavides, Manuel, Carles Pericay, Manuel Valladares‐Ayerbes, et al.. (2012). Oxaliplatin in Combination With Infusional 5-Fluorouracil as First-Line Chemotherapy for Elderly Patients With Metastatic Colorectal Cancer: A Phase II Study of the Spanish Cooperative Group for the Treatment of Digestive Tumors. Clinical Colorectal Cancer. 11(3). 200–206.
6.
Páez, David, Juliana Salazar, Laia Paré, et al.. (2011). Pharmacogenetic Study in Rectal Cancer Patients Treated With Preoperative Chemoradiotherapy: Polymorphisms in Thymidylate Synthase, Epidermal Growth Factor Receptor, GSTP1, and DNA Repair Genes. International Journal of Radiation Oncology*Biology*Physics. 81(5). 1319–1327.
7.
Páez, David, Laia Paré, Albert Altés, et al.. (2010). Thymidylate synthase germline polymorphisms in rectal cancer patients treated with neoadjuvant chemoradiotherapy based on 5-fluorouracil. Journal of Cancer Research and Clinical Oncology. 136(11). 1681–1689.
8.
Villavicencio, Humberto, Ó. Rodríguez Faba, Joan Palou, et al.. (2010). Bladder Preservation Strategy Based on Combined Therapy in Patients with Muscle-Invasive Bladder Cancer: Management and Results at Long-Term Follow-Up. Urologia Internationalis. 85(3). 281–286.
9.
Páez, David, Laia Paré, Íñigo Espinosa, et al.. (2010). Immunoglobulin G fragment C receptor polymorphisms and KRAS mutations: Are they useful biomarkers of clinical outcome in advanced colorectal cancer treated with anti‐EGFR‐based therapy?. Cancer Science. 101(9). 2048–2053.
10.
Paré, Laia, David Páez, Juliana Salazar, et al.. (2010). Absence of large intragenic rearrangements in the DPYD gene in a large cohort of colorectal cancer patients treated with 5‐FU‐based chemotherapy. British Journal of Clinical Pharmacology. 70(2). 268–272.
11.
Hoskins, Janelle M., Eugenio Marcuello, Albert Altés, et al.. (2008). Irinotecan Pharmacogenetics: Influence of Pharmacodynamic Genes. Clinical Cancer Research. 14(6). 1788–1796.
12.
Abad, Albert, Bartomeu Massutí, Antonio Antón, et al.. (2008). Colorectal cancer metastasis resectability after treatment with the combination of oxaliplatin, irinotecan and 5-fluorouracil. Final results of a phase II study. Acta Oncologica. 47(2). 286–292.
13.
Marcuello, Eugenio, José Antonio González, Manuel Rodríguez, et al.. (2007). Resección quirúrgica de metástasis hepáticas de cáncer colorrectal. Experiencia del Hospital de Sant Pau. Cirugía Española. 81(6). 339–344.
14.
Roé, Esther, Maria Pilar García Muret, Eugenio Marcuello, et al.. (2006). Description and management of cutaneous side effects during cetuximab or erlotinib treatments: A prospective study of 30 patients. Journal of the American Academy of Dermatology. 55(3). 429–437.
15.
Abad, Albert, Alfredo Carrato, Matilde Navarro, et al.. (2005). Two Consecutive Phase II Trials of Biweekly Oxaliplatin plus Weekly 48-Hour Continuous Infusion of Nonmodulated High-Dose 5-Fluorouracil as First-Line Treatment for Advanced Colorectal Cancer. Clinical Colorectal Cancer. 4(6). 384–389.
16.
Casanova, Isolda, Matilde Parreño, Lourdes Farré, et al.. (2005). Celecoxib induces anoikis in human colon carcinoma cells associated with the deregulation of focal adhesions and nuclear translocation of p130Cas. International Journal of Cancer. 118(10). 2381–2389.
17.
Marcuello, Eugenio, et al.. (2004). Single nucleotide polymorphism in the 5′ tandem repeat sequences of thymidylate synthase gene predicts for response to fluorouracil‐based chemotherapy in advanced colorectal cancer patients. International Journal of Cancer. 112(5). 733–737.
18.
Risques, Rosa‐Ana, Vı́ctor Moreno, Eugenio Marcuello, et al.. (2001). Redefining the Significance of Aneuploidy in the Prognostic Assessment of Colorectal Cancer. Laboratory Investigation. 81(3). 307–315.
19.
Tórtola, Silvia, Eugenio Marcuello, Rosa‐Ana Risques, et al.. (1999). Overall deregulation in gene expression as a novel indicator of tumor aggressiveness in colorectal cancer. Oncogene. 18(30). 4383–4387.
20.
Izquierdo, Miguel, et al.. (1993). Unresectable nonmetastatic squamous cell carcinoma of the esophagus managed by sequential chemotherapy (cisplatin and bleomycin) and radiation therapy. Cancer. 71(2). 287–292.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Janja Ocvirk Breakdown of academic impact, for papers by H. Kröning Breakdown of academic impact, for papers by Stephen A. Cullinan Breakdown of academic impact, for papers by Tadamichi Denda Breakdown of academic impact, for papers by Rosella Spadi Breakdown of academic impact, for papers by Isabel Chirivella Breakdown of academic impact, for papers by George P. Kim Breakdown of academic impact, for papers by Marie‐Pierre Galais Breakdown of academic impact, for papers by Cristina Grávalos Breakdown of academic impact, for papers by Yihebali Chi